Chaisawasthomrong Chonnawee, Boongird Atthaporn
Division of Neurosurgery, Department of Surgery, Ratchaburi Hospital, Ratchaburi, Thailand.
Division of Neurosurgery, Department of Surgery, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.
Neurosurg Rev. 2025 Feb 20;48(1):255. doi: 10.1007/s10143-025-03403-6.
Hematoma volume is a significant concern in basal ganglia hemorrhage, with no clear cutoff to guide the choice between conservative and surgical management, particularly for larger hematomas where the optimal approach remains controversial. This study aimed to determine the maximum hematoma volume suitable for conservative treatment and the volume that necessitates surgical intervention in patients with basal ganglia hemorrhage. A total of 387 cases of basal ganglia hemorrhage from 2019 to 2021 were analyzed, evaluating patient demographics, medical history, and initial CT brain scans to assess hematoma volume. Outcomes of medical and surgical treatments were compared using multivariate logistic and Cox regression analysis. For patients treated with medical management alone, mortality rates did not differ significantly between hematoma volumes of 10-39.9 mL and those under 10 mL. Receiver operating characteristic (ROC) curve analysis identified a cutoff volume of 45.3 mL, with a sensitivity of 80.82% and specificity of 91.67% for predicting survival. Kaplan-Meier survival analysis revealed a reduced mortality hazard ratio (0.17) with surgical intervention for hematomas exceeding 45.3 mL. However, surgical treatment for volumes under 30 mL was associated with higher mortality compared to medical management. Surgical intervention showed a clear survival benefit for hematoma volumes of at least 60 mL, while conservative treatment remained appropriate for volumes up to 45.3 mL. For volumes between 45.3 mL and 59.9 mL, the decision to operate should be guided by the surgeon's judgment and patient-specific factors such as comorbidities, brain atrophy. In conclusion, conservative management is effective for hematomas up to 45.3 mL, while surgical intervention is absolutely indicated for volumes of 60 mL or more. These findings provide valuable guidance for optimizing treatment strategies in basal ganglia hemorrhage.
血肿体积是基底节区出血的一个重要问题,目前尚无明确的临界值来指导保守治疗和手术治疗的选择,特别是对于较大的血肿,最佳治疗方法仍存在争议。本研究旨在确定适合保守治疗的最大血肿体积以及基底节区出血患者需要进行手术干预的体积。分析了2019年至2021年共387例基底节区出血病例,评估患者的人口统计学特征、病史和初始脑部CT扫描以评估血肿体积。使用多因素逻辑回归和Cox回归分析比较了内科治疗和手术治疗的结果。对于仅接受内科治疗的患者,血肿体积在10 - 39.9 mL和小于10 mL之间的死亡率无显著差异。受试者工作特征(ROC)曲线分析确定临界体积为45.3 mL,预测生存的敏感性为80.82%,特异性为91.67%。Kaplan-Meier生存分析显示,对于血肿体积超过45.3 mL的患者,手术干预可降低死亡风险比(0.17)。然而,与内科治疗相比,体积小于30 mL的手术治疗死亡率更高。对于至少60 mL的血肿体积,手术干预显示出明显的生存益处,而对于体积达45.3 mL的血肿,保守治疗仍然适用。对于体积在45.3 mL至59.9 mL之间的情况,手术决策应根据外科医生的判断以及患者的特定因素,如合并症、脑萎缩等。总之,保守治疗对于体积达45.3 mL的血肿有效,而对于60 mL及以上的血肿则绝对需要进行手术干预。这些发现为优化基底节区出血的治疗策略提供了有价值的指导。